Embryo transfer in IVF/ICSI. Other obstetric conditions, not elsewhere classified
Conditions
Interventions
Intervention 1: An insulin syringe will be placed at the end of the catheter immediately after embryo transfer, and 0.2 ml air will be pushed, then the catheter will be slowly taken out. Intervention
Placebo
An insulin syringe will be placed at the end of the catheter immediately after embryo transfer, and 0.2 ml air will be pushed, then the catheter will be slowly taken out
In control group, no intervention will be done. To blind the study, an insulin syringe will be taken by physician and will be pretended that it is placed at the end of the catheter for pushing air.
Sponsors
Royan Institute
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Women undergoing IVF or ICSI treatment cycle, patients with "long or antagonist" protocol Exclusion Criteria: The patients with frozen-thawed embryo transfer cycle, those with oocyte donation cycle, the women with uterine abnormality, women with submucosal and intramural myoma, Who does not have good-quality embryos
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: 4-6 weeks after embryo transfer. Method of measurement: observing the pregnancy sac. | — |
Secondary
| Measure | Time frame |
|---|---|
| Implantation rate. Timepoint: 6-7 weeks after embryo transfer. Method of measurement: number of pregnancy sacs. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Tahereh Madani
Royan Instituite
Outcome results
None listed